RxDoctor Payments Data

Lori Newman

Family Medicine · Washington, DCNPI 1982809513

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Alnylam Pharmaceuticals Inc.. That places this record below the midpoint for family medicine clinicians in DC, where the typical reported total is $110.

$42in general payments, 2019–2025

Across 1 payment — averaging $42.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alnylam Pharmaceuticals Inc.$42
$2,761,498in research payments, 2019–2025

Across 2 payments — averaging $1,380,749 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$2.8M

What the payments were for

  • Food & beverage$42100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Alnylam Pharmaceuticals Inc.1$42

How this compares

$42 in reported general payments places this provider in the 30th percentile of 166 family medicine providers in District of Columbia.

See all family medicine providers in District of Columbia

Other family medicine in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →